DGAP-News: SYNIMMUNE GmbH Reports Interim Results of First-in-Human Study of Fc-Optimized Antibody F...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_wirefeeds_2323018375

DGAP-News: SYNIMMUNE GmbH Reports Interim Results of First-in-Human Study of Fc-Optimized Antibody FLYSYN for the Treatment of Acute Myeloid Leukemia

Full title

DGAP-News: SYNIMMUNE GmbH Reports Interim Results of First-in-Human Study of Fc-Optimized Antibody FLYSYN for the Treatment of Acute Myeloid Leukemia

Publisher

Munich: EQS Group AG

Journal title

DGAP Deutsche Gesellschaft für Ad-hoc-Publizität. Corporate News, 2019

Language

English

Formats

Publisher

Munich: EQS Group AG

Subjects and topics

Full title

DGAP-News: SYNIMMUNE GmbH Reports Interim Results of First-in-Human Study of Fc-Optimized Antibody FLYSYN for the Treatment of Acute Myeloid Leukemia

Record Identifier

TN_cdi_proquest_wirefeeds_2323018375

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_wirefeeds_2323018375

Log in as a Library member

Celebrating and sharing stories of Indigenous Australia, and helping to locate and prioritise Indigenous voices in the Library's collections.

Learning programs and resources linked to the curriculum.

Showcasing people, places and ideas inspired by the collection and the library community.